Gasparri, Maria Luisa Kuehn, Thorsten Ruscito, Ilary Zuber, Veronica Di Micco, Rosa Galiano, Ilaria Navarro Quinones, Siobana C. Santurro, Letizia Di Vittorio, Francesca Meani, Francesco Bassi, Valerio Ditsch, Nina Mueller, Michael D. Bellati, Filippo Caserta, Donatella Papadia, Andrea Gentilini, Oreste D. 2021 Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is an experimental procedure to reduce lymphatic morbidity. The aim of our systematic review and meta-analysis is to investigate the effects of fibrin sealants on lymphatic morbidity after axillary dissection. Our results show that this experimental procedure is able to decrease the total axillary drainage output, the number of days before the axillary drainage is removed, and the length of hospital stay. However, no effects on the occurrence rate of axillary lymphocele or on the surgical site complications rate were demonstrated Background: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. Methods: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. Results: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin’s disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). Conclusion: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found. application/pdf https://localhost:5000/ark:/12658/srd1319276 https://susi.usi.ch/global/documents/319276 https://susi.usi.ch/documents/319276/files/papadia_c_2021.pdf eng info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13092056 info:eu-repo/semantics/altIdentifier/ark/12658/srd1319276 info:eu-repo/semantics/openAccess CC BY Cancers. - MDPI. - 2021, vol. 13, no. 9, p. 15 Axillary lymphadenectomy Breast cancer Fibrin sealant Lymphatic morbidity Lymphocele info:eu-repo/classification/udc/61 Fibrin sealants and axillary lymphatic morbidity : a systematic review and meta-analysis of 23 clinical randomized trials http://purl.org/coar/resource_type/c_6501